Beth Taylor Sells 4,370 Shares of Inotiv, Inc. (NASDAQ:NOTV) Stock

Inotiv, Inc. (NASDAQ:NOTV) CFO Beth Taylor sold 4,370 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $4.01, for a total transaction of $17,523.70. Following the completion of the transaction, the chief financial officer now directly owns 108,368 shares in the company, valued at $434,555.68. This represents a 3.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Beth Taylor also recently made the following trade(s):

• On Friday, January 31st, Beth Taylor sold 2,054 shares of Inotiv stock. The shares were sold at an average price of $4.46, for a total value of $9,160.84.

Inotiv Trading Down 4.5 %

Shares of NASDAQ NOTV opened at $4.06 on Friday. The company has a market cap of $136.90 million, a price-to-earnings ratio of -0.88 and a beta of 3.58. The stock’s 50 day simple moving average is $4.33 and its 200 day simple moving average is $2.95. The company has a current ratio of 1.57, a quick ratio of 1.28 and a debt-to-equity ratio of 2.31. Inotiv, Inc. has a 12-month low of $1.23 and a 12-month high of $11.42.

Inotiv (NASDAQ:NOTV) last announced its quarterly earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. Equities research analysts expect that Inotiv, Inc. will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Inotiv

Several large investors have recently made changes to their positions in NOTV. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new stake in Inotiv in the 4th quarter valued at approximately $60,000. Virtu Financial LLC acquired a new position in shares of Inotiv during the fourth quarter valued at $76,000. Two Sigma Advisers LP increased its holdings in shares of Inotiv by 31.6% during the fourth quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock valued at $93,000 after purchasing an additional 5,400 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Inotiv by 24.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 31,626 shares of the company’s stock worth $131,000 after purchasing an additional 6,216 shares during the period. Finally, LPL Financial LLC bought a new position in Inotiv in the 4th quarter valued at about $136,000. Institutional investors and hedge funds own 18.17% of the company’s stock.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.